Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

923.50p
   
  • Change Today:
      15.50p
  • 52 Week High: 1,445.00
  • 52 Week Low: 576.50
  • Currency: UK Pounds
  • Shares Issued: 124.77m
  • Volume: 25,106
  • Market Cap: £1,152.25m
  • RiskGrade: 314

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1.9% 23.2%
ROCE n/a  
Latest F'cast
P/E n/a 9.5
PEG n/a n/a
Pr/Revenue 1.3 1.1
Pr/Book n/a  
Latest F'cast
Revenue 8.7% -34.1%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Indivior Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 647.00 (173.00) 40.00¢ 18.3 n/a -67% n/a 0.0%
31-Dec-21 791.00 190.00 19.20¢ 90.2 n/a -52% n/a 0.0%
31-Dec-22 901.00 (95.00) (38.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1,093.00 1.00 1.00¢ 1,597.4 n/a n/a n/a 0.0%
31-Dec-24 1,188.00 (43.00) (36.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Indivior Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 1,056.02 245.17 96.02p 9.5 n/a n/a n/a 0.0%
31-Dec-26 1,087.93 259.32 107.21p 8.5 0.7 +12% n/a 0.0%
31-Dec-27 1,146.12 294.02 124.08p 7.3 0.5 +16% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Indivior Company Announcements

Director/PDMR Shareholding 15-May-2025 15:30 RNS
Indivior to Participate in Upcoming Events 13-May-2025 15:00 RNS
Amendment to Result of AGM 09-May-2025 16:37 RNS

Indivior ShareCast News

Indivior shrinks board following pressure from a... 04-Mar-2025 ShareCast
London close: Stocks mixed on corporate earnings... 27-Feb-2025 ShareCast
Pharma veteran Ciaffoni to take CEO reins at Ind... 27-Feb-2025 ShareCast

Latest Indivior Director Deals

Traded Action Notifier PriceAmountValue
05-May-25 Buy Mark Stejbach 902.62p 1,000 £9,026.22
17-Mar-25 Transfer From Mark Crossley 0.000p 9,974 £0.00
10-Mar-25 Transfer From Mark Crossley 0.000p 243,282 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Indivior Market Data

Currency UK Pounds
Share Price 923.50p
Change Today 15.50p
% Change 1.71 %
52 Week High 1,445.00
52 Week Low 576.50
Volume 25,106
Shares Issued 124.77m
Market Cap £1,152.25m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.8% below the market average54.8% below the market average54.8% below the market average54.8% below the market average54.8% below the market average
34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average
Price Trend
67.44% above the market average67.44% above the market average67.44% above the market average67.44% above the market average67.44% above the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average
Income Not Available
Growth
51.10% above the market average51.10% above the market average51.10% above the market average51.10% above the market average51.10% above the market average
13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
11:13 4 @ 923.75p
11:13 8 @ 923.75p
11:13 12 @ 923.75p
11:13 37 @ 923.75p
11:13 25 @ 923.50p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page